Highest-materiality recent filing
Non-reliance on FY2024, FY2025 audited financials and 8 quarterly periods due to accounting error on USD-denominated share-settled warrants misclassified as equity.
Acquired all MTL shares for ~41.2M CGC shares + C$18.5M cash; 0.32 CGC share + C$0.144 cash per MTL share.
Canopy Q3 net loss narrows 49% YoY; Canada cannabis revenue up 4% to $52M
Net loss narrowed 49% YoY; Adjusted EBITDA loss narrowed 17% to $3M; free cash outflow improved to $19M.
Term loan net proceeds of US$150M (US$162M principal with OID), interest at Term SOFR +6.25% (floor 3.25%), matures Jan 2031.
Canopy Growth to acquire MTL Cannabis in stock-and-cash deal valued at ~38M shares + C$17M
Exchange ratio: 0.32 CGC share + C$0.144 cash per MTL share; aggregate approx. 38M CGC shares and C$17M cash.
Canopy Growth Q2 revenue $67M (+6% YoY); going concern doubt resolved
Canada adult-use net revenue $24M, up 30% YoY; Canada medical $22M, up 17%.
Canopy Growth shareholders approve reverse stock split at 1:5 to 1:15 ratio
Share consolidation (reverse split) authorized with ratio of 1 post-split for every 5-15 pre-split shares, Board to set exact ratio before Sep 26, 2026.
Canopy Growth launches $200M at-the-market equity program to strengthen financial position
New ATM program authorizes up to $200M in common shares, with up to $50M sold in Canada.
Canopy Growth Q1 FY2026 cannabis revenue up 24% YoY; appoints Shan Atkins to board
Cannabis net revenue $57M (+24% YoY); Canada adult-use up 43% to $27M on infused PRJ demand.
Canopy Growth to prepay US$50M of term loan, expects US$6.5M annual interest savings
Agrees to three prepayments: US$25M on July 31, 2025; US$10M by Dec 31, 2025; US$15M by Mar 31, 2026.
Canopy Growth Q4 revenue down 11% YoY to $65M; adjusted EBITDA loss improves 39% to $9.2M
Net revenue $65M in Q4 FY2025, down 11% YoY; net loss from continuing ops $221.5M.
Canopy Growth Reports Q3 FY2025 Results: Revenue Down 5%, Adjusted EBITDA Improves 61%
Net revenue was $74.8M, down 5% YoY but up 8% excluding divestitures.
Canopy USA completes acquisition of Acreage; CGC issues ~5.89M shares for deal value ~$21.2M
Canopy USA owns 100% of Acreage as of Dec 9, 2024; combined with Wana and Jetty for U.S. cannabis platform.
Canopy Growth names board member Luc Mongeau as CEO, effective Jan 6, 2025
Luc Mongeau, CPG veteran and board member since Feb 2024, becomes CEO on Jan 6, 2025; David Klein steps down to special advisor.
Canopy Growth Q2 revenue down 9% to $63M; adjusted EBITDA loss improves 54% to $5.5M
Net revenue $63.0M, down 9% YoY; excluding divested businesses, up 3%.
Canopy Growth prepays US$100M of term loan at discount; saves ~US$14M annually
Prepaid US$100M principal at discounted price of US$97.5M, reducing leverage.
Canopy Growth announces CEO David Klein to retire by March 31, 2025; board begins successor search
CEO David Klein will retire by March 31, 2025; remains CEO until successor appointed or that date.
Canopy Growth Q1 revenue $66.2M (-13% YoY); gross profit up 67%; extends term loan to Dec 2026
Gross profit $23M (+67% YoY); gross margin 35% (+1,700 bps) on cost savings and medical mix.
Canopy Growth enters $250M at-the-market equity distribution agreement
Up to $250M (or equivalent CAD) of common shares may be sold through BMO Capital Markets (US) and BMO Nesbitt Burns (Canada).
Canopy Growth exercises Acreage share option, acquires $99.8M debt, closes Wana/Jetty buys
Exercised Fixed Share Call Option to acquire all Acreage Class E shares; closing subject to conditions.
Canopy Growth Q4 net revenue up 7% YoY to $72.8M; adjusted EBITDA loss improves 63%
Q4 net revenue $72.8M (+7% YoY); Storz & Bickel net revenue up 43% to $22.2M on Venty sales.
Canopy Growth enters debt exchange for US$50M proceeds, extends C$27.5M debt to 2029
Gross proceeds ~US$50M; exchanges C$27.5M of 2025 debt for new C$96.4M convertible debenture maturing 2029.
appointed Luc Mongeau, a current member of the Board, to serve as Chief Executive Officer (“CEO”) of the Company (the “Appointment”), effective January 6, 2025
Mr. Klein will continue in his role as CEO and a member of the Board until the Start Date, at which time Mr. Klein will step down from the Board and will serve as Special Advisor
On August 15, 2024, Canopy Growth Corporation (the “Company”) entered into a Mutual Separation Agreement (the “Separation Agreement”) with David Klein, the Company’s Chief Executive Officer (“CEO”), pursuant to which Mr. Klein will remain as CEO until the earlier of: (i) March 31, 2025; or (ii) the date that a new CEO commences employment (the “End Date”).
Max materiality 0.85 · Median 0.70 · Most common event other_material